Login / Signup

State Medicaid Restrictions for Direct-Acting Antiviral Therapy Do Not Impact Posttransplant Outcomes of Recipients of Hepatitis C Virus-Viremic Livers.

Manasa NarasimmanDavid S Goldberg
Published in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2020)
Keyphrases
  • hepatitis c virus
  • human immunodeficiency virus
  • health insurance
  • affordable care act
  • kidney transplantation
  • type diabetes
  • mesenchymal stem cells
  • adipose tissue
  • glycemic control